Kenley Jansen placed on 15-day IL with pelvic inflammation after early exit

What happened

Detroit placed right-hander Kenley Jansen on the 15-day injured list with pelvic inflammation, the club announced. Left-hander Drew Sommers was recalled to fill the open roster spot.

The move follows a difficult in-game exit. Jansen entered in the ninth inning with Detroit leading 4-0, faced three batters, and recorded two outs before a trainer visit prompted his departure. Brenan Hanifee came on to record the final out. Per MLB Trade Rumors, the underlying groin and abdomen issue had been present for a few weeks before the IL placement.

Why it matters

The 15-day IL is the standard designation for pitchers under general league rules, and it means Jansen will be unavailable to the Tigers bullpen for at least that stretch. What makes the timing notable is that this is not a new problem — it is a recurring one.

Per Cody Stavenhagen of The Athletic, the club announced on May 2nd that Jansen had been dealing with the same groin and abdomen ailment and was being managed at that time. From April 30th through May 9th, he made only one appearance — a semi-rest period that stopped short of an IL trip. He was able to pitch for the past few weeks after that, but per MLB Trade Rumors, the issue flared up again the night of his early exit. The IL placement, then, is less a surprise than a conclusion the situation had been building toward.

The financial backdrop adds a layer of context. Jansen was signed to an $11MM deal in the offseason, making him one of the more significant bullpen investments Detroit made entering 2026. When a closer-caliber arm at that price point is unavailable, the ripple through a bullpen is real — even if the Tigers, at this stage of their season, are navigating different pressures than a club in a pennant race.

The numbers

Through 15 innings this season, Jansen carries a 4.80 ERA, per MLB Trade Rumors. His strikeout rate sits at 30.6%. MLB Trade Rumors noted that his performance this season has not been at his best, and attributed that, at least in part, to the injury.

A 30.6% strikeout rate is not a figure that signals a pitcher who has lost his stuff entirely — that would play in most bullpens on most nights. The ERA over those 15 innings tells a different story, and the physical context the source provides suggests the two data points may not be unrelated. Whether the pelvic inflammation has been affecting his mechanics, his pitch execution, or simply his availability is not something the material specifies. MLB Trade Rumors raises the connection as a reasonable inference, not a clinical finding.

Where the club stands

Detroit enters Thursday at 76-86 (.469), fourth in the AL Central and 9 games back in the division. The Tigers have been eliminated from both the division race and the Wild Card race, and arrive at Thursday's home game against the Los Angeles Angels on a one-game losing streak.

The probable pitchers for Thursday's game at Comerica Park are Jack Flaherty for Detroit and Grayson Rodriguez for Los Angeles. Friday and Saturday take the Tigers on the road to Rate Field in Chicago for a two-game set against the White Sox, with Troy Melton projected to start Friday against Erick Fedde, and Framber Valdez lined up for Saturday against Anthony Kay.

For a club already eliminated from postseason contention, the calculus around Jansen's IL stint is less about October and more about organizational health — keeping a veteran arm from compounding a nagging injury into something more serious, and getting a look at what Drew Sommers can do with a roster spot.

Is Jansen expected back quickly?

The 15-day IL sets the minimum window, but MLB Trade Rumors does not specify a timetable for his return. What the material does establish is that this issue has been managed, flared, managed again, and has now flared a second time — a pattern that does not lend itself to confident short-term projections. Under general league rules, a pitcher on the 15-day IL can be transferred to the 60-day IL if the situation warrants, though no such move has been reported here.

The club's announcement used the term "pelvic inflammation," which is a more specific characterization than the "groin/abdomen issue" language that had been in circulation since early May per Stavenhagen's reporting. Whether that represents a refined diagnosis or simply a more formal description of the same underlying problem is not something the source clarifies.

What we don't know yet

MLB Trade Rumors does not provide a return timetable, a prognosis beyond the IL placement itself, or any detail about what treatment or next steps look like. It is also not clear from the material whether the Tigers intend to use Sommers in a high-leverage role or primarily as a depth option while Jansen is unavailable.

The precise relationship between the physical issue and the 4.80 ERA through 15 innings is not established with any clinical specificity in the source — worth preserving as a distinction rather than collapsing into a tidy narrative.

What to watch

The most immediate question is how Detroit configures its late-inning options without Jansen available. Sommers' recall fills the roster spot, but MLB Trade Rumors does not indicate whether he steps into any particular role. With three games coming up against the Angels and White Sox, the bullpen usage patterns over the next week will offer the first real read on how the Tigers are redistributing the workload.

Longer term, the pattern here — a managed period in early May, a brief return to action, and then a flare-up severe enough to prompt an in-game exit and an IL placement — suggests this is a situation worth monitoring even after Jansen is eligible to return. The 15-day clock is a floor, not a forecast, and the club has not offered anything beyond the placement itself to indicate what comes next.

For a team already playing out the string in the standings, the organizational priority is presumably getting Jansen healthy rather than rushing him back for games that carry no playoff weight. Whether that patience translates into a clean return or a longer absence is, for now, genuinely unknown.